Karin van Dijk
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 28
- Fungal Infections and Studies 16
-
- Antifungal resistance and susceptibility 19
- Antimicrobial Resistance in Staphylococcus 4
- Co-authors
- Johanna G. van der Bom (7 shared papers)Kathelijn Fischer (6 shared papers)H. Marijke van den Berg (6 shared papers)Christina M. J. E. Vandenbroucke‐Grauls (5 shared papers)Paul E. Verweij (7 shared papers)Johannes C. F. Ket (2 shared papers)Greetje A. Kampinga (3 shared papers)D. E. Grobbee (1 shared paper)
- Journals
- Clinical Microbiology and Infection (3 papers)Haemophilia (2 papers)Blood (2 papers)Future Microbiology (2 papers)BMC Infectious Diseases (2 papers)
- Partner nations
- NetherlandsUnited StatesFrance
In The Last Decade
Karin van Dijk
57 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 102
- Molecular Medicine 240
- Applied Microbiology and Biotechnology 87
- Hematology 402
- Infectious Diseases 468
- Endocrinology 121
Countries citing papers authored by Karin van Dijk
This map shows the geographic impact of Karin van Dijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin van Dijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin van Dijk more than expected).
Fields of papers citing papers by Karin van Dijk
This network shows the impact of papers produced by Karin van Dijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin van Dijk. The network helps show where Karin van Dijk may publish in the future.
Co-authors
The 25 scholars most cited alongside Karin van Dijk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 166 | |
| 2 | 2017 | 160 | |
| 3 | 2013 | 107 | |
| 4 | 2017 | 107 | |
| 5 | 2002 | 104 | |
| 6 | 2005 | 98 | |
| 7 | Factor VIII half-life and clinical phenotype of severe hemophilia A. | 2005 | 73 |
| 8 | 2005 | 72 | |
| 9 | 2020 | 62 | |
| 10 | 2023 | 61 | |
| 11 | 2020 | 60 | |
| 12 | 2009 | 56 | |
| 13 | 2004 | 51 | |
| 14 | Use of implantable venous access devices in children with severe hemophilia: benefits and burden. | 2004 | 37 |
| 15 | 1999 | 37 | |
| 16 | 2002 | 35 | |
| 17 | 2012 | 27 | |
| 18 | 2010 | 26 | |
| 19 | 2019 | 21 | |
| 20 | 2019 | 21 |
About Karin van Dijk
Karin van Dijk is a scholar working on Epidemiology, Infectious Diseases, Molecular Medicine, Hematology and Molecular Biology, having authored 63 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (19 papers), Fungal Infections and Studies (16 papers), Antibiotic Resistance in Bacteria (10 papers), Hemophilia Treatment and Research (9 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Bacterial Identification and Susceptibility Testing (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Platelet Disorders and Treatments (4 papers). The work is most often cited by research in Molecular Medicine (240 citations), Applied Microbiology and Biotechnology (87 citations), Hematology (402 citations), Infectious Diseases (468 citations) and Endocrinology (121 citations). Karin van Dijk has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Johanna G. van der Bom, Kathelijn Fischer, H. Marijke van den Berg, Christina M. J. E. Vandenbroucke‐Grauls, Paul E. Verweij, Johannes C. F. Ket, Greetje A. Kampinga, D. E. Grobbee, Diederick E. Grobbee and K.D. Liem. Their work appears in journals such as Clinical Microbiology and Infection, Haemophilia, Blood, Future Microbiology and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.